as 12-18-2024 12:45pm EST
Stocks
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.
Founded: | 1999 | Country: | Israel |
Employees: | N/A | City: | N/A |
Market Cap: | 2.3M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 15.5K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -23.29 | EPS Growth: | N/A |
52 Week Low/High: | $2.70 - $10.43 | Next Earning Date: | 12-27-2024 |
Revenue: | $57,642,000 | Revenue Growth: | -47.73% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
XYLO Breaking Stock News: Dive into XYLO Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 months ago
GlobeNewswire
4 months ago
GlobeNewswire
4 months ago
GlobeNewswire
5 months ago
GlobeNewswire
5 months ago
GlobeNewswire
6 months ago
GlobeNewswire
6 months ago
GlobeNewswire
7 months ago
The information presented on this page, "XYLO XYLO TECHNOLOGIES LTD - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.